Your browser doesn't support javascript.
loading
Progress in vaccine development for infectious diseases-a Keystone Symposia report.
Cable, Jennifer; Graham, Barney S; Koup, Richard A; Seder, Robert A; Karikó, Katalin; Pardi, Norbert; Barouch, Dan H; Sharma, Bhawna; Rauch, Susanne; Nachbagauer, Raffael; Forsell, Mattias N E; Schotsaert, Michael; Ellebedy, Ali H; Loré, Karin; Irvine, Darrell J; Pilkington, Emily; Tahtinen, Siri; Thompson, Elizabeth A; Feraoun, Yanis; King, Neil P; Saunders, Kevin; Alter, Galit; Moin, Syed M; Sliepen, Kwinten; Karlsson Hedestam, Gunilla B; Wardemann, Hedda; Pulendran, Bali; Doria-Rose, Nicole A; He, Wan-Ting; Juno, Jennifer A; Ataca, Sila; Wheatley, Adam K; McLellan, Jason S; Walker, Laura M; Lederhofer, Julia; Lindesmith, Lisa C; Wille, Holger; Hotez, Peter J; Bekker, Linda-Gail.
Afiliação
  • Cable J; PhD Science Writer, New York, New York, USA.
  • Graham BS; Morehouse School of Medicine, Atlanta, Georgia, USA.
  • Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Seder RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Karikó K; BioNTech SE, Mainz, Germany.
  • Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Barouch DH; Harvard Medical School, Boston, Massachusetts, USA.
  • Sharma B; Gilead Sciences, Foster City, California, USA.
  • Rauch S; CureVac AG, Tübingen, Germany.
  • Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Forsell MNE; Moderna, Cambridge, Massachusetts, USA.
  • Schotsaert M; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Ellebedy AH; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Loré K; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, New York, New York, USA.
  • Irvine DJ; Department of Pathology and Immunology; Center for Vaccines and Immunity to Microbial Pathogens; and The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Pilkington E; Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Tahtinen S; Koch Institute for Integrative Cancer Research; Department of Biological Engineering; and Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Thompson EA; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, California, USA.
  • Feraoun Y; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • King NP; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Saunders K; Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
  • Alter G; Genentech, South San Francisco, California, USA.
  • Moin SM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sliepen K; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.
  • Karlsson Hedestam GB; Department of Biochemistry and Institute for Protein Design, University of Washington, Seattle, Washington, USA.
  • Wardemann H; Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
  • Pulendran B; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • Doria-Rose NA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • He WT; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Juno JA; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Ataca S; Division of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Wheatley AK; Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford University, Stanford, California, USA.
  • McLellan JS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Walker LM; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, California, USA.
  • Lederhofer J; Department of Immunology and Microbiology and IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.
  • Lindesmith LC; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Wille H; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Hotez PJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Bekker LG; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
Ann N Y Acad Sci ; 1524(1): 65-86, 2023 06.
Article em En | MEDLINE | ID: mdl-37020354

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Doenças Transmissíveis / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Doenças Transmissíveis / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article